polydeoxyribonucleotide
Small moleculeexperimental
Clinical trial activity
5 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
4
Earliest trial started Oct 1, 2007 (NCT00638872)
Timeline
No events for the selected filters.
Indications
Approved for
Mechanism of action
- Adenosine receptor A2a and A3ACTIVATOR
Adenosine receptor A2a and A3 activator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- polydeoxyribonucleotide
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04401735 | Phase 4 | Nov 1, 2019 | Seoul National University |
| NCT03916198 | Phase 4 | Apr 30, 2019 | Government of Korea, Hallym University |
| NCT03388255 | Phase 4 | Nov 8, 2016 | A.O. Ospedale Maggiore di Lodi, Mastelli srl, via Bussana Vecchia, Sanremo, Italy, Sintesi Research Srl |
| NCT06753630 | N/A | Nov 20, 2014 | Hallym University |
| NCT00638872 | Phase 4 | Oct 1, 2007 | Mastelli srl, via Bussana Vecchia, Sanremo, Italy, University of Messina |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hallym University | Academic/Hospital | 2 | 2 | 2 | 2014 |
| Mastelli srl, via Bussana Vecchia, Sanremo, Italy | For profit | 2 | 1 | 1 | 2007 |
| A.O. Ospedale Maggiore di Lodi | Academic/Hospital | 1 | 0 | 1 | 2016 |
| Government of Korea | Government | 1 | 0 | 1 | 2019 |
| Seoul National University | Academic/Hospital | 1 | 1 | 1 | 2019 |
| Sintesi Research Srl | For profit | 1 | 0 | 1 | 2016 |
| University of Messina | Academic/Hospital | 1 | 1 | 1 | 2007 |
7 organizations
Page 1 / 1